Skip to main content
Subscribe
  • Login
  • My Account
  • Logout
  • Register For Free
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HLTH 2024
    • Sponsored Content: Vital Signs Blog
  • Opinion
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • 40 Under 40
    • Best Places to Work in Healthcare
    • Healthcare Marketing Impact Awards
    • Innovators Awards
    • Diversity Leaders
    • Leading Women
    • Best in Business Awards
    • The 2030 Playbook Conference
    • Innovations in Patient Experience
    • Leading Women Conference & Awards Luncheon
    • Leadership Summit
    • Workforce Summit
    • Best Places to Work Awards Gala
    • Diversity Leaders Gala
    • - Looking Ahead to 2025
    • - Financial Growth
    • - Hospital of the Future
    • - Value Based Care
    • - Looking Ahead to 2026
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Skilled Nursing Facilities
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
    • Sponsored Content
MENU
Breadcrumb
  1. Home
  2. Finance
February 12, 2013 11:00 PM

Global solution needed for illegitimate meds: IOM

Jessica Zigmond
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    Yunker

    The trade in illegitimate medications is a global public health problem that requires a global solution, according to a nearly 300-page report from the Institute of Medicine.

    Commissioned by the U.S. Food and Drug Administration, the report centers on two categories of poor-quality drugs: substandard, or those that don't meet the specifications in an accepted pharmacopeia or manufacturer's standards; and falsified, or those that carry a false representation of identity, or source, or both.

    While those kinds of drugs often contain toxic ingredients, the more common problem is that they don't work, the report noted. For example, poor-quality drugs have led to the rise of drug-resistant tuberculosis, and drug-resistant staphylococcus infections are appearing in India, Latin America and sub-Saharan Africa. Citing the Pharmaceutical Security Institute—a network of 25 pharmaceutical companies' security divisions—the report noted that the illegal trade and manufacture of medications affected at least 124 countries in 2011, with developing countries hit hardest.

    Consequently, the IOM said the World Health Assembly (the decisionmaking arm of the World Health Organization) should work with the United Nations Office on Drugs and Crime and the World Customs Organization to establish a transparent process for developing a code of practice on falsified and substandard medicines. That code should include guidelines on surveillance, regulation and law enforcement, and it should enable states and the international community to both prevent and respond to drug-quality problems.

    Meanwhile, the report found secondary wholesalers to be the weakest link in the U.S. drug distribution chain. “What we're seeing in the United States—and doubly so in developing countries—is a race to the bottom,” Lawrence Gostin, director of the WHO's Collaborating Center on Public Health Law and Human Rights, said in a news release about the report. “Unscrupulous drug suppliers seek the state or country with the weakest regulatory and law enforcement standards. We need to encourage a status competition for the finest regulatory oversight.”

    The IOM recommends that state licensing boards only license wholesalers and distributors that meet the National Association of Boards of Pharmacy accreditation standards, and that the FDA—together with state licensing boards—should establish a public database to share information on suspended and revoked wholesale licenses. It also recommends that Congress authorize and fund the FDA to establish a track-and-trace system that would give each product a unique identifier. Until then, the FDA should set up working groups of stakeholders that include the International Federation of Pharmaceutical Manufacturers and Associations and the Generic Pharmaceutical Association to promote voluntary tracking and tracing for all supply-chain players.

    “This new report reiterates what we have long known: the infiltration of our global supply chain with dangerous, illegitimate drugs is a serious public health problem,” Rep. Henry Waxman (D-Calif.), ranking member of the House Energy and Commerce Committee, said in a statement. “California has already passed a law to require individual units of drugs to be accounted for at each step along the supply chain. I hope we can pass a law at the federal level that provides the same level of protection as California's model legislation.”

    Last fall, Waxman and other members of the Energy and Commerce Oversight and Investigations Subcommittee questioned FDA Administrator Margaret Hamburg about why the agency didn't do more to prevent a deadly fungal meningitis outbreak linked to a contaminated injectable steroid at the New England Compounding Center in Framingham, Mass. The IOM report cited the company's “negligent production” in the report.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    tariffs-healthcare-money-finance-0225
    How health system CFOs are navigating the growing uncertainty
    value based care integrated
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    Most Popular
    1
    Here are new state healthcare laws taking effect in 2025
    2
    Meet Modern Healthcare's 2025 Leading Women
    3
    New York-Presbyterian layoffs affect 2% of employees
    4
    Evernorth, Optum, CenterWell units buoyed insurers in Q1
    5
    Epic CEO Judy Faulkner on AI, antitrust and consolidation
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2025. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HLTH 2024
      • Sponsored Content: Vital Signs Blog
    • Opinion
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • 40 Under 40
        • Best Places to Work in Healthcare
        • Healthcare Marketing Impact Awards
        • Innovators Awards
        • Diversity Leaders
        • Leading Women
        • Best in Business Awards
      • Conferences
        • The 2030 Playbook Conference
        • Innovations in Patient Experience
        • Leading Women Conference & Awards Luncheon
        • Leadership Summit
        • Workforce Summit
      • Galas
        • Best Places to Work Awards Gala
        • Diversity Leaders Gala
      • Virtual Briefings
        • - Looking Ahead to 2025
        • - Financial Growth
        • - Hospital of the Future
        • - Value Based Care
        • - Looking Ahead to 2026
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Skilled Nursing Facilities
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing
      • Sponsored Content